OR-RADISYS
19.3.2020 09:02:04 CET | Business Wire | Press release
Radisys® Corporation , a global leader of open telecom solutions, today announced the global availability of the Radisys Engage Video Assistant (EVA), the world’s first app-less AI-powered 3-in-1 (video, voice, text) bot for digital customer interactions. The EVA empowers customer support, sales and marketing teams to significantly enhance the customer experience by delivering greater personalization that drives customer acquisition, retention, and satisfaction with the cost savings of automation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200319005010/en/
Customers can access the EVA to interact visually with sales professionals, subject-matter-experts, brand ambassadors, brand influencers, and customer care agents – simply by dialing a regular customer support number, using a Video over LTE (ViLTE) capable 4G/LTE or 5G smartphone, or by clicking a link on the website with no download required. The EVA can also be integrated with mobile apps. EVA’s powerful AI engine determines the customer’s intent and delivers the right information, and when required it supports the transition of the bot interaction to live agents to ensure a consistent and seamless customer experience and the most cost-effective use of live agents.
As a white label solution, the EVA offers service providers a platform with flexible deployment options, either in-network or accessible from the cloud. It enables new revenue streams by providing Video Call Bot-as-a-Service for call centers, SMBs and large enterprise customers, and it can reduce contact centers’ costs by automating interactions – like how-to interactions or sophisticated troubleshooting – that are underserved by voice or text bots alone.
Key Takeaways
- Today’s technologies provide tools that can control and improve the digital customer experience by creating self-service customer engagement. However, while chatbots, voice-enabled digital assistants, and other similar automation technologies are enabling businesses to achieve cost-effective scalability and agility, they lack a human touch needed for a satisfactory customer experience.
- The Engage Video Assistant application allows service providers, call centers and businesses to:
- Humanize existing calls and interactive mobile or voice apps with video while maintaining an authentic visual brand persona.
- Create video FAQs for new product launches or common customer support issues.
- Enhance existing bots and cumbersome interactive voice response (IVR) solutions.
- Scale influencers and brand ambassadors to unprecedented levels through personalized customer interactions.
- Engage customers at their time of choice – day or night, weekday or holiday – with personalized video interactions.
- Engage Video Assistant is deployed by Reliance Jio, the world’s largest VoLTE service provider, serving 370 million subscribers in India and helping its business customers to enhance their customer service, reduce their customer support cost, and enhance agent productivity.
“Radisys’ app-less calling experience enables businesses and service providers to offer an unprecedented in-call experience to their customers,” said Alan Quayle, independent consultant and founder, TADHack and TADHack Summit. “Its ease of integration lowers customer support costs; and improves productivity by helping customers get what they need faster, with a personal touch.”
“Video is a proven way to create greater immersion, increase click-throughs, and convert connections to purchases,” said Al Balasco, vice president, communications solutions, Radisys. “Engage Video Assistant is the first digital engagement bot application to combine video, voice and text seamlessly to provide ubiquitous and customizable brand and customer service reach for B2B and B2C customer interactions anywhere, anytime.”
About Radisys
Radisys is a global leader in open telecom solutions and services. Its disaggregated platforms and integration services leverage open reference architectures and standards combined with open software and hardware, enabling service providers to drive open digital transformation. Radisys offers an end-to-end solutions portfolio from digital end points, to disaggregated and open access and core solutions, to immersive digital applications and engagement platforms. Its world-class and experienced network services organization delivers full lifecycle services to help service providers build and operate highly scalable and high-performance networks at optimum total cost of ownership. For more information, visit www.Radisys.com .
Radisys® is a registered trademark of Radisys. All other trademarks are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200319005010/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
